Dechra Pharmaceuticals

What are the treatment options?

If it can be determined that there is a tumor of the adrenal gland, surgical removal of the tumor may be an option, although the risks of this procedure can be high. However, it is not usually possible to remove pituitary gland tumors (the most frequent cause of Cushing’s syndrome).

The alternative to surgery is medical management. VETORYL is the only licensed treatment available for both pituitary-dependent hyperadrenocorticism (PDH) and adrenal-dependent hyperadrenocorticism (ADH) in the United States and Europe.

VETORYL Capsules contain the active ingredient trilostane.

Although the daily administration of VETORYL does not offer a medical cure for Cushing’s syndrome, it may allow the disease to be managed successfully, enhancing the dog’s vitality and quality of life.

  • Vetoryl
  • FDA Compounding Letter 
  • Vetoryl Client Brochure 
  • Vetoryl Technical Brochure
  • Vetoryl Technical Brochure 
Country
Search
  • Global
  • Denmark
  • Finland
  • France
  • Germany
  • Netherlands
  • Ireland
  • Norway
  • Spain
  • Sweden
  • United Kingdom
  • USA
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Global
  • Holland
  • Ireland
  • Norway
  • Spain
  • Sweden
  • UK
  • USA

Search
Search